Mimetogen Pharmaceuticals

About:

Mimetogen Pharmaceuticals is a clinical-stage ophthalmology drug development company.

Top Investors: Inovia Capital, Schooner Capital, MSBi Valorisation, VIMAC Milestone Medical Fund, Medwell Capital

Description:

Mimetogen Pharmaceuticals Inc. is a clinical-stage ophthalmology drug development company developing peptidomimetics for dry eye, retinitis pigmentosa, dry AMD and glaucoma.

Total Funding Amount:

$3.65M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Montréal, Quebec, Canada

Founded Date:

2004-01-01

Contact Email:

info(AT)mimetogen.com

Founders:

Garth Cumberlidge, Uri Saragovi

Number of Employees:

1-10

Last Funding Date:

2013-07-18

IPO Status:

Private

Industries: